Hsp70 Chaperone Ligands Control Domain Association via an Allosteric Mechanism Mediated by the Interdomain Linker

Hsp70 chaperones assist in protein folding, disaggregation, and membrane translocation by binding to substrate proteins with an ATP-regulated affinity that relies on allosteric coupling between ATP-binding and substrate-binding domains. We have studied single- and two-domain versions of the E. coli...

Full description

Saved in:
Bibliographic Details
Published in:Molecular cell Vol. 26; no. 1; pp. 27 - 39
Main Authors: Swain, Joanna F., Dinler, Gizem, Sivendran, Renuka, Montgomery, Diana L., Stotz, Mathias, Gierasch, Lila M.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 13-04-2007
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hsp70 chaperones assist in protein folding, disaggregation, and membrane translocation by binding to substrate proteins with an ATP-regulated affinity that relies on allosteric coupling between ATP-binding and substrate-binding domains. We have studied single- and two-domain versions of the E. coli Hsp70, DnaK, to explore the mechanism of interdomain communication. We show that the interdomain linker controls ATPase activity by binding to a hydrophobic cleft between subdomains IA and IIA. Furthermore, the domains of DnaK dock only when ATP binds and behave independently when ADP is bound. Major conformational changes in both domains accompany ATP-induced docking: of particular importance, some regions of the substrate-binding domain are stabilized, while those near the substrate-binding site become destabilized. Thus, the energy of ATP binding is used to form a stable interface between the nucleotide- and substrate-binding domains, which results in destabilization of regions of the latter domain and consequent weaker substrate binding.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
Present address: Drug Metabolism and Pharmacokinetics (DMPK), Schering-Plough Research Institute, Kenilworth, NJ 07033
Present address: Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Present address: Interfakultäres Institut für Biochemie, Universität Tübingen, 72076 Tübingen Germany
Present address: Faculty of Engineering and Natural Sciences, Sabanci University, Orhanli, Tuzla, Istanbul, 34956 Turkey
ISSN:1097-2765
1097-4164
DOI:10.1016/j.molcel.2007.02.020